Submitted by Anonymous (not verified) on 26 January 2026 - 15:43
Human medicines European public assessment report (EPAR): Seebri Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 14, Status: Authorised
Source: